Literature DB >> 23138185

Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization.

S Li, J Fu, H Ma, M Y Mapara, S Lentzsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23138185     DOI： 10.1038/leu.2012.323

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Authors:  Kelly Faulk; Lia Gore; Todd Cooper
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

2.  Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.

Authors:  Kota Yoshifuji; Takashi Toya; Hiroto Adachi; Masahiro Fujita; Atsushi Wada; Ryosuke Konuma; Yuya Kishida; Tatsuya Konishi; Akihito Nagata; Yuta Yamada; Satoshi Kaito; Takuma Kumagai; Kyoko Inamoto; Megumi Akiyama; Aiko Igarashi; Yuho Najima; Noriko Doki; Takeshi Kobayashi; Kazuhiko Kakihana; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Int J Hematol       Date:  2019-04-13       Impact factor: 2.490

3.  Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease.

Authors:  Jing Fu; Shirong Li; Rentian Feng; Huihui Ma; Farideh Sabeh; G David Roodman; Ji Wang; Samuel Robinson; X Edward Guo; Thomas Lund; Daniel Normolle; Markus Y Mapara; Stephen J Weiss; Suzanne Lentzsch
Journal:  J Clin Invest       Date:  2016-04-04       Impact factor: 14.808

Review 4.  Initial Therapeutic Approaches to Patients with Multiple Myeloma.

Authors:  Hadi E Berbari; Shaji K Kumar
Journal:  Adv Ther       Date:  2021-06-18       Impact factor: 3.845

5.  A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

Authors:  R Silvennoinen; P Anttila; M Säily; T Lundan; J Heiskanen; T M Siitonen; S Kakko; M Putkonen; H Ollikainen; V Terävä; A Kutila; K Launonen; A Räsänen; A Sikiö; M Suominen; P Bazia; K Kananen; T Selander; T Kuittinen; K Remes; E Jantunen
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

6.  Impact of lenalidomide exposure on blood cell collection for autotransplants in persons with POEMS syndrome.

Authors:  Hao Cai; Jiefei Bai; Jian Li; Huacong Cai; Minghui Duan; Xinxin Cao; Miao Chen; Daobin Zhou; Wei Zhang
Journal:  Arch Med Sci       Date:  2016-11-02       Impact factor: 3.318

Review 7.  Current status of autologous stem cell transplantation for multiple myeloma.

Authors:  Rama Al Hamed; Abdul Hamid Bazarbachi; Florent Malard; Jean-Luc Harousseau; Mohamad Mohty
Journal:  Blood Cancer J       Date:  2019-04-08       Impact factor: 11.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.